Pharmafile Logo
Pharmafocus logo
Advanced Search

SMC accepts amivantamab and lazertinib for EGFR-positive lung cancer

May 22, 2026
SMC, amivantamab, lazertinib, lung cancer

The Scottish Medicines Consortium (SMC) has accepted Rybrevant (amivantamab) in combination with Lazcluze (lazertinib) for use within NHS Scotland as …

News

BioDuro and CTI Biotechnology in preclinical drug development partnership

May 21, 2026
Research and Development BioDuro, CTI Biotechnology

BioDuro has announced a strategic partnership with CTI Biotechnology. The collaboration will leverage the complementary strengths of both companies across critical stages …

News

Sygnature Discovery appoints Susanne Back as Head of In Vivo Pharmacology

May 21, 2026
Sygnature Discovery, Vivo Pharmacology

Sygnature Discovery, an integrated drug discovery contract research organisation (CRO), has announced the appointment of Susanne Back as Head of …

Appointment

NICE recommends sotatercept for pulmonary arterial hypertension

May 20, 2026
NICE, Winrevair, pulmonary arterial hypertension, sotatercept

The National Institute for Health and Care Excellence (NICE) has recommended Winrevair (sotatercept) as a treatment option for adults with …

News

Vetter begins construction of new injectable medicines facility

May 20, 2026
Manufacturing and Production Vetter

Vetter, a contract development and manufacturing organisation (CDMO), has begun construction of a new pharmaceutical manufacturing site in Saarlouis, Germany, …

News

Study explores genomic testing approach for unexplained infertility

May 14, 2026
Research and Development infertility

Researchers across the Asia Pacific region have reported findings from a study investigating whether long-read whole genome sequencing could improve …

News

Celtic Renewables receives £7m to develop bio-based solvents

May 14, 2026
Manufacturing and Production Celtic Renewables

Scottish green chemicals company Celtic Renewables is part of a consortium that has secured £7m in funding to support development …

News

Synnovis and SOPHiA GENETICS expand liquid biopsy testing in NHS cancer care

May 13, 2026
Research and Development Sophia Genetics, Synnovis

Synnovis and SOPHiA GENETICS have announced a collaboration to expand blood-based cancer testing for patients with lung and breast cancer …

News

MHRA to establish Northern Ireland hub for life sciences sector

May 13, 2026
MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is establishing a new hub in Northern Ireland aimed at strengthening engagement …

News

Shilpa Medicare signs manufacturing deal with NXI Therapeutics

May 12, 2026
Manufacturing and Production Shilpa Medicare

Shilpa Medicare has entered into a long-term development and manufacturing agreement with Swiss biotech company NXI Therapeutics focused on an …

News

CGT Catapult backs AI platform for gene therapy delivery

May 12, 2026
Cell and Gene Therapy Catapult

Cell and Gene Therapy Catapult (CGT Catapult) is providing investment to UK biotech company Lir Therapeutics to support development of …

News

Campaign highlights low expectations among patients with depression

May 7, 2026
Johnson & Johnson, major depressive disorder (MDD)

A new global awareness campaign from Johnson & Johnson is aiming to encourage people with major depressive disorder (MDD) to …

News

Practical AI toolkit launched to help manufacturers cut through complexity

May 6, 2026
Manufacturing and Production AI, Made Smarter

A new guide from Made Smarter is helping manufacturers cut through the noise around AI and focus on what actually …

News

Syngene appoints Maninder Kapoor Puri as CHRO

May 6, 2026
Research and Development Syngene International

Syngene International, a global contract research, development, and manufacturing organization (CRDMO), has announced the appointment of Maninder Kapoor Puri as …

Appointment

BioPhorum acquires PharmaX Solutions

May 5, 2026
Manufacturing and Production BioPhorum, PharmaX Solutions

BioPhorum has acquired PharmaX Solutions, a consultancy specialising in digital transformation and end-to-end digital manufacturing solutions across pharmaceutical manufacturing and …

News

Syngene appoints Abhijit Zutshi as CCO

May 5, 2026
Research and Development Syngene International

Syngene International, a global contract research, development, and manufacturing organization (CRDMO), has announced the appointment of Abhijit Zutshi as Chief …

Appointment

Japanese pharma outsources earlier as peptide development challenges grow

April 29, 2026
Peptide therapies, peptide

Japanese pharmaceutical companies are increasingly engaging contract development and manufacturing organisations (CDMOs) earlier in the drug development process, as the …

News

Study suggests phospholipid therapy may impact fatty liver disease outcomes

April 29, 2026
Research and Development fatty liver disease, phospholipid therapy

A randomised clinical trial has reported that treatment with essential phospholipids (Essentiale) may reduce liver fat and improve symptoms in …

News

FDA signals support for development of psychedelic therapies in mental healthmental health

April 28, 2026
Neurology, mental health

The US Food and Drug Administration (FDA) has announced a series of measures aimed at supporting the development of psychedelic-based …

News

New web series explores path from ophthalmic research to patient access

April 28, 2026
Research and Development Opthalmology

A new YouTube web series has been launched to examine how ophthalmic innovations progress from early research through to approved …

News

EMA backs plozasiran for rare lipid disorder with high pancreatitis risk

April 27, 2026
Research and Development The European Medicines Agency (EMA), plozasiran

The European Medicines Agency (EMA) has recommended granting a marketing authorisation for Redemplo (plozasiran) to treat adults with familial chylomicronaemia …

News
The Gateway to Local Adoption Series

Latest content

SMC accepts amivantamab and lazertinib for EGFR-positive lung cancer

May 22, 2026

BioDuro and CTI Biotechnology in preclinical drug development partnership

May 21, 2026

Sygnature Discovery appoints Susanne Back as Head of In Vivo Pharmacology

May 21, 2026

NICE recommends sotatercept for pulmonary arterial hypertension

May 20, 2026

Vetter begins construction of new injectable medicines facility

May 20, 2026